AAAAAA

   
Results: 1-20 |
Results: 20
COMPARATIVE-ANALYSIS OF INTERPHASE FISH AND RT-PCR TO DETECT BCR-ABL TRANSLOCATION IN CHRONIC MYELOGENOUS LEUKEMIA AND RELATED DISORDERS
Authors: TBAKHI A PETTAY J SREENAN JJ ABDELRAZEQ H KALAYCIO M HOELTGE G MILLER ML TUBBS RR
Citation: A. Tbakhi et al., COMPARATIVE-ANALYSIS OF INTERPHASE FISH AND RT-PCR TO DETECT BCR-ABL TRANSLOCATION IN CHRONIC MYELOGENOUS LEUKEMIA AND RELATED DISORDERS, AJCP. American journal of clinical pathology, 109(1), 1998, pp. 16-23
CHARACTERIZATION OF THE BREAKPOINTS IN A T(8-13)(P11-Q12) TRANSLOCATION FROM A PATIENT WITH MYELOPROLIFERATIVE DISEASE USING FLUORESCENCE IN-SITU HYBRIDIZATION
Authors: CHERNOVA O STILL I KALAYCIO M HOELTGE G COWELL JK
Citation: O. Chernova et al., CHARACTERIZATION OF THE BREAKPOINTS IN A T(8-13)(P11-Q12) TRANSLOCATION FROM A PATIENT WITH MYELOPROLIFERATIVE DISEASE USING FLUORESCENCE IN-SITU HYBRIDIZATION, Genes, chromosomes & cancer, 21(2), 1998, pp. 160-165
VARIABLES ASSOCIATED WITH THE PLATELET COUNT 6 WEEKS AFTER AUTOLOGOUSPERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION
Authors: BOLWELL B GOORMASTIC M ANDRESEN S KOO A WISE K OVERMOYER B POHLMAN B KALAYCIO M
Citation: B. Bolwell et al., VARIABLES ASSOCIATED WITH THE PLATELET COUNT 6 WEEKS AFTER AUTOLOGOUSPERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION, Bone marrow transplantation, 22(6), 1998, pp. 547-551
DELAYED G-CSF AFTER AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION - A PROSPECTIVE RANDOMIZED TRIAL
Authors: BOLWELL BJ POHLMAN B ANDRESEN S KALAYCIO M GOORMASTIC M WISE K WAKELING A DANNLEY R OVERMOYER B
Citation: Bj. Bolwell et al., DELAYED G-CSF AFTER AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION - A PROSPECTIVE RANDOMIZED TRIAL, Bone marrow transplantation, 21(4), 1998, pp. 369-373
A RANDOMIZED STUDY OF MULTI-DAY INFUSION OF AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR CELLS
Authors: ABDELRAZEQ H POHLMAN B ANDRESEN S KALAYCIO M OVERMOYER B WISE K DANNLEY R DEMARS D GOORMASTIC M BOLWELL B
Citation: H. Abdelrazeq et al., A RANDOMIZED STUDY OF MULTI-DAY INFUSION OF AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR CELLS, Bone marrow transplantation, 21(3), 1998, pp. 221-223
CONTINUOUS-INFUSION GRANISETRON COMPARED TO ONDANSETRON FOR THE PREVENTION OF NAUSEA AND VOMITING AFTER HIGH-DOSE CHEMOTHERAPY
Authors: KALAYCIO M MENDEZ Z POHLMAN B OVERMOYER B BOPARAI N JONES E BOLWELL B
Citation: M. Kalaycio et al., CONTINUOUS-INFUSION GRANISETRON COMPARED TO ONDANSETRON FOR THE PREVENTION OF NAUSEA AND VOMITING AFTER HIGH-DOSE CHEMOTHERAPY, Journal of cancer research and clinical oncology, 124(5), 1998, pp. 265-269
INPATIENT MANAGEMENT OF ACUTE-LEUKEMIA
Authors: KALAYCIO M
Citation: M. Kalaycio, INPATIENT MANAGEMENT OF ACUTE-LEUKEMIA, Cleveland Clinic journal of medicine, 64(7), 1997, pp. 385-389
PROGRESSIVE DISEASE AFTER ABMT FOR HODGKINS-DISEASE
Authors: BOLWELL BJ KALAYCIO M GOORMASTIC M DANNLEY R ANDRESEN SW LICHTIN A OVERMOYER B POHLMAN B
Citation: Bj. Bolwell et al., PROGRESSIVE DISEASE AFTER ABMT FOR HODGKINS-DISEASE, Bone marrow transplantation, 20(9), 1997, pp. 761-765
PLATELET TRANSFUSION REQUIREMENTS DURING AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION CORRELATE WITH THE PRETRANSPLANT PLATELET COUNT
Authors: BOLWELL BJ GOORMASTIC M ANDRESEN S OVERMOYER B POHLMAN B KALAYCIO M
Citation: Bj. Bolwell et al., PLATELET TRANSFUSION REQUIREMENTS DURING AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION CORRELATE WITH THE PRETRANSPLANT PLATELET COUNT, Bone marrow transplantation, 20(6), 1997, pp. 459-463
FACTORS ASSOCIATED WITH DELAYED G-CSF PRIMED PBPC COLLECTION
Authors: BOLWELL B OVERMOYER B KALAYCIO M GOORMASTIC M ANDRESEN S DANNLEY R WISE K DEMARS D POHLMAN B
Citation: B. Bolwell et al., FACTORS ASSOCIATED WITH DELAYED G-CSF PRIMED PBPC COLLECTION, Blood, 90(10), 1997, pp. 4201-4201
THE G-CSF PRIMED WBC CORRELATES WITH CD34+ CELL YIELD
Authors: BOLWELL B POHLMAN B OVERMOYER B ANDRESEN S GOORMASTIC M DANNLEY R SERAFIN M LICHTIN A WISE K KALAYCIO M
Citation: B. Bolwell et al., THE G-CSF PRIMED WBC CORRELATES WITH CD34+ CELL YIELD, Blood, 90(10), 1997, pp. 4202-4202
AUTOLOGOUS BLOOD DONATION PRIOR TO ALLOGENEIC BONE-MARROW HARVEST
Authors: DOMEN R POHLMAN B KALAYCIO M SERAFINO S ANDRESEN S GOORMASTIC M BOLWELL B
Citation: R. Domen et al., AUTOLOGOUS BLOOD DONATION PRIOR TO ALLOGENEIC BONE-MARROW HARVEST, Blood, 90(10), 1997, pp. 4212-4212
BREAST-CANCER PATIENTS HAVE A HIGHER PLATELET COUNT 6 WEEKS AFTER AUTOLOGOUS PBPC TRANSPLANT THAN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
Authors: BOLWELL B OVERMOYER B GOORMASTIC M KALAYCIO M ANDRESEN S DANNLEY R WISE K SERAFIN M WAKELING A POHLMAN B
Citation: B. Bolwell et al., BREAST-CANCER PATIENTS HAVE A HIGHER PLATELET COUNT 6 WEEKS AFTER AUTOLOGOUS PBPC TRANSPLANT THAN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Blood, 90(10), 1997, pp. 4348-4348
MATCHED UNRELATED BONE-MARROW TRANSPLANTATION (MUD BMT) FOR ACUTE-LEUKEMIA
Authors: ALDAABIL R BOLWELL B POHLMAN B SANDS K DANNLEY R CURTIS J KALAYCIO M
Citation: R. Aldaabil et al., MATCHED UNRELATED BONE-MARROW TRANSPLANTATION (MUD BMT) FOR ACUTE-LEUKEMIA, Blood, 90(10), 1997, pp. 4517-4517
CLADRIBINE (2CDA) FOR THE PREVENTION OF ACUTE GRAFT-VS-HOST DISEASE (GVHD)
Authors: KALAYCIO M POHLMAN B CURTIS J DANNLEY R BOPARAI N SANDS K BOLWELL B
Citation: M. Kalaycio et al., CLADRIBINE (2CDA) FOR THE PREVENTION OF ACUTE GRAFT-VS-HOST DISEASE (GVHD), Blood, 90(10), 1997, pp. 448-448
EFFECTIVE TREATMENT FOR POOR-RISK ACUTE MYELOGENOUS LEUKEMIA (AML) - A POTENTIAL ROLE FOR TIMED SEQUENTIAL THERAPY WITH CONCOMITANT G-CSF
Authors: GEORGE C TRIPP B HUSSEIN M LICHTIN A ANDRESEN S OVERMOYER B POHLMAN B KALAYCIO M
Citation: C. George et al., EFFECTIVE TREATMENT FOR POOR-RISK ACUTE MYELOGENOUS LEUKEMIA (AML) - A POTENTIAL ROLE FOR TIMED SEQUENTIAL THERAPY WITH CONCOMITANT G-CSF, Blood, 88(10), 1996, pp. 3419-3419
BONE-MARROW TRANSPLANTATION (BMT) IS EFFECTIVE THERAPY FOR LEUKEMIA IN AFRICAN-AMERICANS
Authors: KALAYCIO M BOLWELL B
Citation: M. Kalaycio et B. Bolwell, BONE-MARROW TRANSPLANTATION (BMT) IS EFFECTIVE THERAPY FOR LEUKEMIA IN AFRICAN-AMERICANS, Blood, 88(10), 1996, pp. 3826-3826
STEM-CELL INFUSION OVER 2 OR 3 DAYS DOES NOT ENHANCE AUTOLOGOUS PROGENITOR-CELL TRANSPLANATION (ABMT) ENGRAFTMENT - A RANDOMIZED STUDY
Authors: ABDELRAZEQ H ANDRESEN S GOORMASTIC M KALAYCIO M OVERMOYER B WISE K DANNLEY R DEMARS D POHLMAN B BOLWELL B
Citation: H. Abdelrazeq et al., STEM-CELL INFUSION OVER 2 OR 3 DAYS DOES NOT ENHANCE AUTOLOGOUS PROGENITOR-CELL TRANSPLANATION (ABMT) ENGRAFTMENT - A RANDOMIZED STUDY, Blood, 88(10), 1996, pp. 453-453
PLATELET TRANSFUSION REQUIREMENTS DURING AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION (ABMT) CORRELATE WITH THE PRETRANSPLANT PLATELET COUNT
Authors: BOLWELL B ANDRESEN S KALAYCIO M DANNLEY R SERAFIN M WISE K MENDEZ Z OVERMOYER B GOORMASTIC M POHLMAN B
Citation: B. Bolwell et al., PLATELET TRANSFUSION REQUIREMENTS DURING AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION (ABMT) CORRELATE WITH THE PRETRANSPLANT PLATELET COUNT, Blood, 88(10), 1996, pp. 477-477
LATE RELAPSE AFTER ABMT FOR HODGKINS-DISEASE
Authors: BOLWELL B WAKELING A DANNLEY R GOORMASTIC M ANDRESEN S LICHTIN A OYERMOYER B POHLMAN B KALAYCIO M
Citation: B. Bolwell et al., LATE RELAPSE AFTER ABMT FOR HODGKINS-DISEASE, Blood, 88(10), 1996, pp. 478-478
Risultati: 1-20 |